MAPT and Alzheimer disease: This is supported by the NIA-AA Research Framework: “Toward a biological definition of Alzheimer’s disease”, which proposes that neurodegeneration is a downstream consequence of tau aggregation pathology in the AD continuum and when it occurs in the absence of tau pathology, a non-AD-related change is considered [95].